Endicott Biofuels

About Endicott Biofuels

Endicott Biofuels, LLC operated in the alternative energy sector as a second-generation biodiesel company, founded in 2006. The firm focused on constructing and managing biorefineries to convert non-food, agricultural waste feedstocks into biodiesel intended to be cost-competitive with petroleum-based fuels. The company's business model revolved around producing and wholesaling biofuel to the brokerage market, aiming to increase the domestic supply of renewable transportation fuel.

A significant milestone for the Houston-based company was the establishment of a long-term technical partnership in 2008 with Davy Process Technology Ltd., a subsidiary of Johnson Matthey. This collaboration allowed Endicott to use Davy's proprietary esterification technology, which was adapted for biodiesel production from waste feedstocks like fats, oils, and greases. The process was notable for its ability to handle feedstocks with up to 100% free fatty acid (FFA), materials typically considered waste by conventional industries. In 2011, Endicott formed a joint venture, Sabine Biofuels LLC, with Holly Corporation to construct and operate a 30-million-gallon-per-year biorefinery in Port Arthur, Texas. This facility, commissioned in January 2013, was designed to produce Endicott's trademarked G2 Clear™ biodiesel.

The company's leadership included CEO David Robinson, appointed in 2008, who brought extensive experience in petroleum refining and chemical process development. Principals of the firm included Christopher Frantz and Richard Wyatt. Endicott secured $40 million in equity financing from Haddington Ventures in 2007. The company's pathway for producing biodiesel from various waste oils received approval from the U.S. Environmental Protection Agency (EPA) under the Renewable Fuel Standard 2 (RFS2) program, confirming a greater than 50% reduction in greenhouse gas emissions compared to diesel. The company was acquired and ceased operations on December 1, 2018.